project id: TCGA-CESC; case submitter id: TCGA-C5-A1MN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.6; spectrophotometer method: UV Spec; age at index: 42; days to birth: -15499; days to death: 1245; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1965; year of death: 2010; age at diagnosis: 15499; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; days to collection: 1441; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-C5-A1MN-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0;